2020 OCT 27 First Case Study Shows Zelenko Protocol Works (HCQ + ZINC + AZM)

It took months of denials, an endorsement from President Trump, and many misrepresented studies, but a case study of Dr. Zelenko’s protocol has finally been published, and it shows he was right.
Dr. Vladimir Zelenko

GOOGLE A Serious Violators of the 1st Amendment
FACEBOOK A Serious Violators of the 1st Amendment
YOUTUBE A Serious Violators of the 1st Amendment
TWITTER A Serious Violators of the 1st Amendment
4CM_Telegram-thumbs-up-400w-480h.fw
Internet_Archive_thumbs-up-400w-480h.fw
bitchute-thumbs-up-400w-480h.fw
Gab_thumbs-up-400w-480h.fw
parler-thumbs-up-400w-480h.fw

Remarks: Dr. Zelenko’s protocol has finally been published, and it shows he was right. Hydroxychloroquine (HCQ), Zinc, and Azithromycin (AZM). The study concluded that “Risk stratification-based treatment of COVID-19 outpatients as early as possible after symptom onset with the used triple therapy, including the combination of zinc with low dose hydroxychloroquine, was associated with significantly fewer hospitalizations.” FULL STORY HERE: https://www.4cmitv.com/2020/10/29/2020-oct-27-first-case-study-shows-zelenko-protocol-works-hcq-zinc-azm/

The Fourcm (4cm) Group: 4cminewswire.com  4cmitv.com  4cminews.com  fourcm.net
4cm Social Media: PARLER @Gary4cm  GAB @4cminewsire TWITTER: @4cmtvworld TWITTER: @4cminews YOUTUBE: @GaryGreen4CMiCTV BITCHUTE: @Freedom4CM

CRAIG KELLY MP  HEADLINES: Dr.  Zelenko Was Right[1]facebook @CraigKellyMP https://www.facebook.com/CraigKellyMP/posts/1657847491076545

It took months of denials, an endorsement from President Trump, and many misrepresented studies, but a case study of Dr. Zelenko’s protocol (Hydroxychloroquine + Zinc + AZ) has finally been published, and it shows he was right.

Published on ScienceDirect.com, the peer-reviewed study was the first to look at early, out of hospital treatment of COVID-19 with Zelenko’s protocol of Hydroxychloroquine, Zinc, and Azithromycin.


COVID-19 outpatients – early risk-stratified treatment with zinc plus low dose hydroxychloroquine and azithromycin: a retrospective case series study

Sciencedirect.com File:
S0924857920304258

Authors:
Roland Derwand
Martin Scholz
Vladimir Zelenko

Available online 26 October 2020, 106214

HIGHLIGHTS[2]SEE Highlights url: https://www.sciencedirect.com/science/article/pii/S0924857920304258

• First COVID-19 outpatient study based on risk stratification and early antiviral treatment at the beginning of the disease

• Hydroxychloroquine at low dose in combination with zinc and azithromycin proved to be an effective therapeutic approach against COVID-19

• Significantly reduced hospitalization rates in the treatment group

• Reduced mortality rates in the treatment group

CONCLUSIONS[3]SEE Conclusions url: https://www.sciencedirect.com/science/article/pii/S0924857920304258

Risk stratification-based treatment of COVID-19 outpatients as early as possible after symptom onset with the used triple therapy, including the combination of zinc with low dose hydroxychloroquine, was associated with significantly fewer hospitalizations.


FILE SIZE: 874 kb

PAGES: 32

DOWNLOAD PDF:

Vladimir Zelenko-1-s2.0-S0924857920304258-main

Article First Case Study Shows Zelenko Protocol Works Cont’:

While other studies looked at the effects of Hydroxychloroquine alone, or treatment during the later stages of the COCID-19 infection, this is the first to look at Zelenko’s entire Protocol, including dosages and timetables.

The case study of 141 patients treated within four days of the onset of symptoms was done, using independent public reference data from 377 other confirmed COVID-19 patients of the same community who remained untreated as a “control” or reference.

Of the 141 treated patients, only four were hospitalized vs. 58 of the 377 who went untreated.

Of those treated, only one person died, while thirteen died in the untreated group.

The study concluded that “Risk stratification-based treatment of COVID-19 outpatients as early as possible after symptom onset with the used triple therapy, including the combination of zinc with low dose hydroxychloroquine, was associated with significantly fewer hospitalizations.”

The study also noted that there were no cardiac side effects noted from the treatment.

ORIGINAL SOURCE: Date-stamped: 2020 OCT 27 | Author: Written by CrownHeights.info | Article Title: First Case Study Shows Zelenko Protocol Works | Article Link: principia-scientific.com

Unlike many news and information platforms, 4cminews is free to read, and always will be. There is no paywall here. We are independent, not affiliated with nor representing any political party or business organisation. We want the very best for our readers, nothing more, nothing less. Your support will help us continue to provide factual News about world events and Global Agenda’s.

You can contribute here. Thank you.

4cminewswire support independent media service


Hashtags: #4cminewswire, #ZelenkoProtocol, #Hydroxychloroquine, #HCQ, #Zinc, #Azithromycin, #AZM, #VladimirZelenko, #4cminews, #4CMiTV, #4CM2020OCT26

Tags: 4cminewswire, Zelenko Protocol, Hydroxychloroquine, HCQ, Zinc, Azithromycin, AZM, Vladimir Zelenko, 4cminews, 4CMiTV, #4CM2020OCT26






References

1 facebook @CraigKellyMP https://www.facebook.com/CraigKellyMP/posts/1657847491076545
2 SEE Highlights url: https://www.sciencedirect.com/science/article/pii/S0924857920304258
3 SEE Conclusions url: https://www.sciencedirect.com/science/article/pii/S0924857920304258

Leave a Reply

Your email address will not be published. Required fields are marked *